Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTristel Regulatory News (TSTL)

Share Price Information for Tristel (TSTL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 445.00
Bid: 440.00
Ask: 450.00
Change: 5.00 (1.14%)
Spread: 10.00 (2.273%)
Open: 440.00
High: 445.00
Low: 440.00
Prev. Close: 440.00
TSTL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

29 Aug 2006 07:01

Tristel PLC29 August 2006 For release29 August 2006 Tristel Plc Technology Acquisition Agreement with IVC Limited, New Zealand Tristel plc ("Tristel"), the chlorine dioxide specialist that supplies infectionand contamination control products to healthcare and institutionalestablishments and the pharmaceutical and food processing industries, announcesthat it has entered into a technology acquisition agreement with IVC Limited, ("IVC"). IVC is Tristel's New Zealand distributor and its principal shareholderis Mark Fraundorfer, an internationally renowned Urologist. Under the terms of the agreement IVC transfers to Tristel the design and patentrights to two inventions which it has created to work specifically withTristel's chlorine dioxide chemistry. The inventions are a sterilizing traysystem which enables single use decontamination of endoscopic equipment and ahygiene work station which enables Tristel's highly effective sporicidalchemistry to be easily applied to floors and walls in high risk wards anddepartments of hospitals. IVC has funded the design and development process to date and transfers theintellectual property created in return for unspecified future royalties. Commenting upon the agreement, Paul Swinney, Chief Executive of Tristel, said: "Outside of the most advanced healthcare markets, where endoscopes are mainlyprocessed in sophisticated and costly automated machines, the majority ofendoscopes are disinfected in basic trays and sinks. These can only holddisinfectant liquids that have to be used repeatedly for many instruments over aperiod of many hours or even days. "The Tristel tray system, combined with Tristel's novel burstable sachet,Tristel Fusion, enables the disinfectant to be used once and to be dedicated toone instrument only. "This achieves one of the key features of the most sophisticated endoscopereprocessing machines at a fraction of their cost, and will help Tristelpenetrate many overseas markets with its chlorine dioxide disinfectants." Tristel plc Parkgreen Communications Ltd Paul Swinney, Chief Executive Paul McManusPaul Barnes, Finance Director Tel 020 7493 3716Tel: 01638 721 500 Mob: 07980 541 893http://www.tristel.com paul.mcmanus@parkgreenmedia.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
13th Dec 20227:00 amRNSIssue of Equity
12th Dec 202211:26 amRNSResult of AGM
12th Dec 20227:00 amRNSAGM Statement
2nd Nov 20221:50 pmRNSHolding(s) in Company
25th Oct 20227:00 amRNSAudited Preliminary Results
6th Oct 20229:15 amRNSIssue of Equity
4th Oct 202212:00 pmRNSAppointment of new Company Secretary
4th Oct 20227:00 amRNSNotice of Results & Investor Presentation
29th Sep 20221:00 pmRNSNorth America update
30th Aug 20227:00 amRNSHolding(s) in Company
22nd Jul 20221:05 pmRNSDirector/PDMR Shareholding
21st Jul 202210:15 amRNSHolding(s) in Company
18th Jul 20224:41 pmRNSSecond Price Monitoring Extn
18th Jul 20224:35 pmRNSPrice Monitoring Extension
18th Jul 20227:00 amRNSTrading update and special dividend
30th Jun 20227:00 amRNSDe Novo FDA submission for Tristel Duo ULT
20th Jun 202210:00 amRNSShareholder Open Day & Notice of Trading update
7th Jun 20221:15 pmRNSHolding(s) in Company
4th May 20227:00 amRNSInvestor Presentation
3rd May 202212:30 pmRNSHolding(s) in Company
14th Apr 202212:00 pmRNSIssue of Equity
6th Apr 202212:10 pmRNSDirector/PDMR Shareholding
5th Apr 20222:45 pmRNSDirector/PDMR Shareholding
29th Mar 20223:40 pmRNSDirector/PDMR Shareholding
23rd Feb 20224:45 pmRNSInterim dividend confirmation
22nd Feb 202211:30 amRNSDirector/PDMR Shareholding
21st Feb 20224:40 pmRNSSecond Price Monitoring Extn
21st Feb 20224:35 pmRNSPrice Monitoring Extension
21st Feb 20227:00 amRNSHalf-year Report
17th Feb 20223:00 pmRNSIssue of Equity
1st Feb 20227:00 amRNSConfirmation of Interim Results
13th Dec 20215:13 pmRNSResult of AGM
13th Dec 20217:00 amRNSAGM Statement and notice of results
27th Oct 20217:00 amRNSDirector/PDMR Shareholding
21st Oct 20214:39 pmRNSDirector/PDMR Shareholding
19th Oct 20215:35 pmRNSHolding(s) in Company
18th Oct 20213:50 pmRNSIssue of Equity
18th Oct 202111:59 amRNSDirector/PDMR Shareholding
18th Oct 20217:00 amRNSFinal Results
12th Oct 20215:58 pmRNSHolding(s) in Company
22nd Sep 20217:00 amRNSNotice of Results
23rd Aug 20217:00 amRNSIssue of Equity
10th Aug 20217:00 amRNSIssue of Equity
29th Jul 20216:29 pmRNSTR1: Notification of Major Holdings
21st Jul 20217:00 amRNSTrading update
9th Jul 20211:21 pmRNSIssue of Equity
24th Jun 20217:00 amRNSRegulatory approval for EPA, Canada & South Korea
8th Jun 20217:00 amRNSIssue of Equity
13th May 20213:30 pmRNSIssue of Equity
26th Apr 20213:15 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.